Monitoring of hormone replacement therapy in postmenopausal women by transvaginal sonography and color flow doppler: study in different phases of sequential.

Slides:

Advertisements

Similar presentations

Carlos Morán, M. D. , Eric Knochenhauer, M. D. , Larry R Boots, Ph. D

Advertisements

Severe maternal morbidity in ectopic pregnancy is not associated with maternal factors but may be associated with quality of care Norah M. van Mello,

Diagnostic Options for Assessment of Postmenopausal Bleeding

The antiandrogenic effect of flutamide improves uterine perfusion in women with polycystic ovary syndrome Silvia Ajossa, M.D., Stefano Guerriero, M.D.,

Gynecologic and hormonal effects of raloxifene in premenopausal women

A method to improve false interpretation of the endometrial echo pattern as homogeneous hyperechogenic Carole Dietterich, R.D.M.S., Kathleen Klausner,

Effect of vitamin E supplementation with and without hormone therapy on circulatory inflammatory markers in postmenopausal women Bruce R. Carr, M.D.,

Hormonal profile and endometrial morphology in letrozole-controlled ovarian hyperstimulation in ovulatory infertile patients Armando Cortínez, M.D.,

Relationship between apoptosis and the number of macrophages in eutopic endometrium from women with and without endometriosis Donald P Braun, Ph.D.,

Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters Enrico Carmina, M.D., Francesco.

Increasing uterine receptivity by decreasing estradiol levels during the preimplantation period in high responders with the use of a follicle-stimulating.

Randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment.

Qi Shen, M. D. , Ying Hua, M. D. , Ph. D. , Wenxiao Jiang, M. D

Laryngeal cytological aspects in women with surgically induced menopause who were treated with transdermal estrogen replacement therapy Salvatore Caruso,

Sclerotherapy with 5% tetracycline is a simple alternative to potentially complex surgical treatment of ovarian endometriomas before in vitro fertilization

Two-year prospective, randomized trial comparing an innovative twice-a-week progestin regimen with a continuous combined regimen as postmenopausal hormone.

Conservative management of cervical ectopic pregnancy

Use of an endoscopic ultrasound probe for the evaluation of the Müllerian rudiments in patients with Rokitansky syndrome Luigi Fedele, M.D., Stefano.

A method to improve false interpretation of the endometrial echo pattern as homogeneous hyperechogenic Carole Dietterich, R.D.M.S., Kathleen Klausner,

Low-dose aspirin and omega-3 fatty acids improve uterine artery blood flow velocity in women with recurrent miscarriage due to impaired uterine perfusion

Modified natural cycle in in vitro fertilization

Evaluation of an ultra-low-dose oral contraceptive for dysmenorrhea: a placebo- controlled, double-blind, randomized trial Tasuku Harada, M.D., Mikio.

Kimberly Elford, M.D., Paul Claman, M.D. Fertility and Sterility

Effect of short-term hormone therapy on oxidative stress and endothelial function in African American and Caucasian postmenopausal women Raymond W Ke,

Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization Ginny Mounce,

Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis

Current methods of tubal patency assessment

Prospective evaluation of luteal phase length and natural fertility

Nonclassic 21-hydroxylase deficiency presenting as endometrial hyperplasia with uterine bleeding in a 67-year-old woman Marguerite B. Vigliani, M.D.,

Efficacy of tibolone as “add-back therapy” in conjunction with a gonadotropin-releasing hormone analogue in the treatment of uterine fibroids Edward.

Sildenafil citrate decreased natural killer cell activity and enhanced chance of successful pregnancy in women with a history of recurrent miscarriage

Pseudoaneurysm of the uterine artery after laparoscopic myomectomy

Endometrial growth and uterine blood flow: a pilot study for improving endometrial thickness in the patients with a thin endometrium Akihisa Takasaki,

Evaluation of two doses of recombinant luteinizing hormone supplementation in an unselected group of women undergoing follicular stimulation for in vitro.

Lifetime expression of stem cell markers in the uterine endometrium

Deoxyribonucleic acid methyltransferases and methyl-CpG-binding domain proteins in human endometrium and endometriosis Kim J.A.F. van Kaam, M.D., Bert.

Prospective evaluation of the ultrasound appearance of the endometrium in a cohort of 1,186 infertile women Christian De Geyter, M.D., Matthias Schmitter,

Midluteal phase Doppler assessment of uterine artery blood flow in nonpregnant women having a history of recurrent spontaneous abortions: correlation.

Thickened endometrial stripe in women with post-menopausal bleeding: an association with a common congenital uterine anomaly M.H. Amols, S.A. El-Nashar,

Uterine artery embolization for fibroids does not have adverse effects on ovarian reserve in regularly cycling women younger than 40 years Giovanna Tropeano,

Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro.

Safety of uterine and/or ovarian preservation in young women with grade 1 intramucous endometrial adenocarcinoma: a comparison of survival according to.

High number of endometrial polyps is a strong predictor of recurrence: findings of a prospective cohort study in reproductive-age women Fang Gu, M.D.,

Endometrial morphology and modulation of hormone receptors during ovarian stimulation for assisted reproductive technology cycles Laura Detti, M.D.,

Pressure lavage under ultrasound guidance: a new approach for outpatient treatment of intrauterine adhesions Maria Elisabetta Coccia, M.D., Ph.D., Carolina.

Mean versus individual hormonal profiles in the menstrual cycle

Goserelin acetate (Zoladex) plus endometrial ablation for dysfunctional uterine bleeding: a 3-year follow-up evaluation J Donnez, M.D., G Vilos, M.D.,

Ovarian endometrioma vascularization in women with pelvic pain

Ectopic pregnancy after transmyometrial embryo transfer: case report

Estrogen therapy increases plasma concentrations of nitric oxide metabolites in postmenopausal women but increases flow-mediated vasodilation only in.

Tibolone reverses the cognitive effects caused by leuprolide acetate administration, improving mood and quality of life in patients with symptomatic uterine.

Regulation of assisted reproductive technologies in the United States

Decreased levels of interleukin-18 in peritoneal fluid but not in serum of patients with endometriosis Xinmei Zhang, M.D., Jun Lin, M.D., Yuli Qian,

Effects of patch or gel estrogen therapies on auditory brainstem response in surgically postmenopausal women: a prospective, randomized study Salvatore.

Quantification of power Doppler energy and its future potential

Variability of serum estrogens among postmenopausal women treated with the same transdermal estrogen therapy and the effect on androgens and sex hormone.

Current evaluation of amenorrhea

Intrauterine instillation of trichloroacetic acid is effective for the treatment of dysfunctional uterine bleeding Mustafa Kucuk, M.D., Tulay Kilic Okman,

Operative transvaginal hydrolaparoscopy for treatment of polycystic ovary syndrome: a new minimally invasive surgery Hervé Fernandez, M.D., Jean-Dominique.

Evaluation of the uterine cavity with magnetic resonance imaging, transvaginal sonography, hysterosonographic examination, and diagnostic hysteroscopy

David H. Barad, M.D., M.S., Norbert Gleicher, M.D.

Luteal phase support Fertility and Sterility

Defining the proliferative phase endometrial defect

Increased endometrial thickness on the day of human chorionic gonadotropin injection does not adversely affect pregnancy or implantation rates following.

Contrast ultrasound: a simple-to-use phase-shifting medium offers saline infusion sonography–like images Dominique de Ziegler, M.D. Fertility and Sterility

Daniel R. Grow, M.D., Khosro Iromloo, M.D. Fertility and Sterility

Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization Ginny Mounce,

Endometrial polyps affect uterine receptivity

Anat Hershko-Klement, M.D., Ronnie Tepper, M.D.

Prospective randomized double-blind trial of the correlation between time of administration and antiestrogenic effects of clomiphene citrate on reproductive.

Presentation transcript:

Monitoring of hormone replacement therapy in postmenopausal women by transvaginal sonography and color flow doppler: study in different phases of sequential therapy Caterina Exacoustòs, M.D., Stefano Lello, M.D., Elisabetta Caporale, M.D., Maria Carla Minghetti, M.D., Donatella Angelozzi, M.D., Domenico Arduini, M.D., Carlo Romanini, M.D. Fertility and Sterility Volume 71, Issue 3, Pages 536-543 (March 1999) DOI: 10.1016/S0015-0282(98)00481-6

FIGURE 1 Phases of the therapeutic cycle in which transvaginal sonography (TVS) and color flow Doppler evaluation (CFD) were performed. Phase E = estrogen phase; phase E/P = estrogen/progestogen phase; phase 0 = after uterine bleeding, no hormonal treatment. Fertility and Sterility 1999 71, 536-543DOI: (10.1016/S0015-0282(98)00481-6)

FIGURE 2 Sonogram showing the multilayered endometrium during the estrogen phase (phase E). Fertility and Sterility 1999 71, 536-543DOI: (10.1016/S0015-0282(98)00481-6)

FIGURE 3 Sonogram showing the echogenic endometrium during the estrogen/progestogen phase (phase E/P). Fertility and Sterility 1999 71, 536-543DOI: (10.1016/S0015-0282(98)00481-6)

FIGURE 4 Scattergram of the mean (± SD) endometrial thickness and single measurements for each patient before treatment and in the three phases of the therapeutic cycle. Phase E = estrogen phase; phase E/P = estrogen/progestogen phase; phase 0 = after uterine bleeding, no hormonal treatment. Fertility and Sterility 1999 71, 536-543DOI: (10.1016/S0015-0282(98)00481-6)

FIGURE 5 Mean (± SD) pulsatility index values before treatment and in the three phases of the therapeutic cycle. Phase E = estrogen phase; phase E/P = estrogen/progestogen phase; phase 0 = after uterine bleeding, no hormonal treatment. Fertility and Sterility 1999 71, 536-543DOI: (10.1016/S0015-0282(98)00481-6)